New committee formed to supervise drug testing in horseracing
Last September 29, 2009, at the recent Racing Medication and Testing Consortium (RMTC) board meeting, held in Louisville, Kentucky, issues such as the consumption of non-steroidal anti-inflammatory drugs (NSAIDs) and how they may affect pre-race exams by regulatory veterinarians were tackled.
The board of directors has accredited the formation of a committee to supervise the implementation of the Drug Testing Initiative (DTI) Task Force recommendations on quality assurance and laboratory accreditation programs for U.S. horse racing drug-testing laboratories.
Dr. Tom David of the Louisiana State Racing Commission and chairman of the ARCI Racing Regulatory Veterinarian Committee explained the examining veterinarian’s interest over current NSAID and corticosteroid policies. RMTC Scientific Advisory Committee was previously appointed with the job of reexamining all existing research on NSAIDs, particularly phenylbutazone.
The RMTC Scientific Advisory Committee has noted different options for consideration in future recommendations on the administration times and threshold concentrations for NSAIDs.
The RMTC previously announced that it was carrying out research on corticosteroids commonly used in racing and the board was updated on the status of that project. A copy of Dr. Soma’s study and Dr. David’s remarks can be found at the RMTC website.
From Harness Link:
At the board meeting, other integrity issues were also discussed in depth, including the use of non-steroidal anti-inflammatory drugs (NSAIDs) and how they may affect pre-race examinations by regulatory veterinarians. Dr. Tom David of the Louisiana State Racing Commission and chairman of the ARCI Racing Regulatory Veterinarian Committee explained the examining veterinarian’s concern over current NSAID and corticosteroid policies.
Tags: corticosteroid, horseracing, RMTC, steroid
Recent Comments